Back to Search
Start Over
Hookipa Pharma reports updated Phase 2 HB-200 combination data at ASCO 2024
- Source :
- The Fly. June 4, 2024
- Publication Year :
- 2024
-
Abstract
- HOOKIPA Pharma announced updated results from its Phase 2 clinical trial of HB-200 in combination with pembrolizumab in patients with recurrent/metastatic human papillomavirus 16 positive head and neck cancer. The [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- The Fly
- Publication Type :
- Periodical
- Accession number :
- edsgcl.796255426